(Reuters) – Tesla Inc is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car maker’s Chief Executive Officer, Elon Musk, tweeted on Wednesday. They are being designed to be shipped to remote lo … Read More »

FRANKFURT (Reuters) – A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday. The drug is one of 17 being tested on … Read More »

FRANKFURT (Reuters) – A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday. The drug is one of 17 being tested on … Read More »

ARMONK, N.Y., June 30, 2020 /PRNewswire/ — IBM (NYSE: IBM) Watson Health® today announced its 2020 Fortune/IBM Watson Health 100 Top Hospitals list and 15 Top Health Systems award winners, naming the top-performing hospitals and health systems in the U.S. Extrapolating the … Read More »

RESEARCH TRIANGLE PARK, N.C. and RIDGEFIELD, Conn., June 30, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX) and Boehringer Ingelheim today announced that the companies have entered into a co-promotion agreement for trilaciclib in the United States and Puerto R … Read More »

(Reuters) – The U.S. Food and Drug Administration on Tuesday released guidance for approving a coronavirus vaccine, saying the vaccine has to prevent or decrease disease severity in at least 50% of people who are inoculated. More than 100 vaccines are being tested worldwide … Read More »

Philadelphia, June 30, 2020 – BW Health Group, a family of interconnected companies dedicated to supporting and building partnerships with the life sciences industry, today announced the appointment of Julie DiMarcantonio-Shorten as Director of Strategic Markets for the New … Read More »

Amsterdam, 30 June 2020: Over recent weeks and months, CPhI Worldwide – organised by Informa Markets – has been in constant discussions with key industry stakeholders and partners to stay abreast of the challenges and complexities facing the different segments of the Pharma … Read More »

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the … Read More »

SAN DIEGO, CA / June 29, 2020  snapIoT Inc., a San Diego-based company, announces Automated AI-powered IRB Packaging and UAT Reporting feature to assemble all patient-facing visual assets and expedite the submission process for IRB and ethics approvals. Traditionally, this t … Read More »

BEIJING (Reuters) – China’s military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics (6185.HK) after clinical trials proved it was safe and showed some efficacy, the company said on Monday. The Ad5-nCoV is … Read More »

Key findings demonstrate value of network solutions to secure and digitalize the pharmaceutical supply chain TraceLink Inc., the leading digital platform company for the life science supply chain, today announced results from its pilot for the Food and Drug Administration (F … Read More »

As COVID-19 continues to rampage across the globe, Brazil stands alongside the U.S. as the countries hardest hit with new infections and deaths. But AstraZeneca and its vaccine hopeful could be coming to save the day now that the drugmaker and Brazilian government have reach … Read More »

Personalizing the Power of Statistical Analysis and Data Visualization King of Prussia, PA  – June 25, 2020: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the launch of its new bu … Read More »

Santiago (Chile), 20 June 2020 – Cells for Cells, a cell therapy- and tissue engineering- focused company, announces that the U.S. Patent and Trademark Office (USPTO) has granted the company a US patent covering the AUTOMATED FABRICATION OF LAYER-BY-LAYER TISSUE ENGINEERED C … Read More »

Survey will gather data from hospital laboratory, blood management, imaging, and data departments across the nation Accumen Inc. is helping healthcare get better, faster. Today the company launched its inaugural, annual National Health System Crisis Readiness Survey, which w … Read More »

June 25, 2020 – Singapore eDevelopment Limited’s (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. has announced proven in vitro success with Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing. Impact Biomedical and Global Research and … Read More »

Partnership with Inofab Health keeps respiratory trials on track and ensures patient safety during and after COVID-19 PHILADELPHIA – June 25, 2020 – ERT, the global leader in clinical endpoints data collection, today announced a strategic partnership with Inofab Health, a he … Read More »

(Reuters) – Doctors in Europe will soon be able to treat COVID-19 patients with Gilead’s antiviral drug, remdesivir, after the healthcare regulator’s endorsement put it on track to become the first therapy for the disease on the continent. The European Medicines Agency (EMA) … Read More »

Ashfield, part of UDG Healthcare, a global leader in commercialisation services for the pharmaceutical and healthcare industry, has announced the appointment of Mike Hodgkiss as UK Head of Quality and Compliance. In his role, Mike will support Ashfield’s commercial and medic … Read More »